Management objectives: increase sales, operating margin, and ROE
First written in FY2018. 4 of 10 entries say "Raised", first in FY2022. Latest entry: 2026-08-10.
The whole theme swung hardest in 2021: 8 of 22 companies on the "Worse" side.
5 other companies' latest entry also says "Raised".
- 2026-08-10RaisedEarnings
「Regarding the full-year consolidated earnings forecast for the fiscal year ending March 2027, the Company has revised upward the full-year consolidated earnings forecast announced on 15 May 2026 as described below, after taking into account the fact that demand in the semiconductor-related market in the Equipment segment substantially exceeded initial expectations during the first quarter and recent order trends.」
The full-year earnings forecast was revised upward based on semiconductor-related demand and order trends. The revision represents an upside to the earnings forecast, distinct from the previous targets of ¥193.0 billion in net sales, ¥28.5 billion in operating income, and ROE targets. - FY2026ReframedAnnual report
「By implementing the measures described above, we will target revenue of at least ¥190 billion, an operating margin of at least 13.7% and ROE of at least 10%.」
After concluding that the 5th Medium-Term Management Plan fell short of its ¥180 billion revenue target, the company set new targets under the 6th Medium-Term Management Plan through the fiscal year ending March 2029 of revenue of at least ¥190 billion, an operating margin of at least 13.7% and ROE of at least 10%. - FY2025ReframedAnnual report
「Our group seeks to enhance corporate value by securing profits while focusing on achieving the targets of each business plan, taking on challenges in new businesses and markets, and pursuing higher revenue and operating margins and stable ROE as management targets.」
The company has reorganized the wording from the previous medium-term plan’s specific numerical targets for the fiscal year ending March 2026 into management metrics focused on achieving each business plan, increasing revenue and operating margin, and maintaining stable ROE. - FY2023AchievedAnnual report
「Compared with the specific management targets of the 5th Medium-Term Management Plan, Exciting CKD 2025, which began in the fiscal year ending March 2023, we exceeded the initial targets for that fiscal year of consolidated revenue of ¥146,000 million and operating profit of ¥18,500 million, while ROE also rose to 12.9%.」
Actual results exceeded the first-year targets of Exciting CKD 2025 of revenue of ¥146,000 million and operating profit of ¥18,500 million, while ROE was 12.9%. - FY2022RaisedAnnual report
「Our specific management targets are consolidated revenue of ¥180,000 million, operating profit of ¥25,000 million and an operating margin of 13.9% for the fiscal year ending March 2026, the final year of the plan. We are targeting an increase in ROE from 10% to 13% over the four years from the fiscal year ending March 2023 through the fiscal year ending March 2026.」
After stating the final-year profit targets for Build-up CKD 2021, the company newly set targets for the fiscal year ending March 2026 under the 5th Medium-Term Management Plan of revenue of ¥180 billion, operating profit of ¥25 billion, an operating margin of 13.9% and ROE of 10%–13%. - FY2021SoftenedAnnual report
「For the fiscal year ending March 2022, the final year of the plan, we will work toward revised targets of net sales of ¥118,000 million, operating profit of ¥11,000 million, an operating margin of 9.3% and ROE of 7.7%.」
Regarding its management metrics, the company has lowered the final-year targets under Build-up CKD 2021 from revenue of ¥143,000 million, operating profit of ¥14,300 million, an operating margin of 10.0% and ROE of at least 9.0%. - FY2020AdvancedAnnual report
「For the fiscal year ending March 2022, the final year of the medium-term management plan, we are working toward achieving revenue of ¥143,000 million, operating profit of ¥14,300 million, an operating margin of 10.0% and ROE of at least 9.0%.」
Previously, the management targets were qualitative targets of higher revenue, operating margin and ROE, but the company disclosed specific numerical targets for the fiscal year ending March 2022. - FY2018First statedAnnual report
「Our group has set higher revenue, operating margin and return on equity (ROE) as management targets. We will also continue to provide stable shareholder returns.」
The company explicitly stated for the first time that higher revenue, operating margin and ROE are management targets, but did not provide specific numerical targets or deadlines.